US20020052336A1 - Method of treating gastrointestinal tract disease with purinergic receptor agonists - Google Patents

Method of treating gastrointestinal tract disease with purinergic receptor agonists Download PDF

Info

Publication number
US20020052336A1
US20020052336A1 US09/747,777 US74777700A US2002052336A1 US 20020052336 A1 US20020052336 A1 US 20020052336A1 US 74777700 A US74777700 A US 74777700A US 2002052336 A1 US2002052336 A1 US 2002052336A1
Authority
US
United States
Prior art keywords
alkyl
p2y
substituted
group consisting
selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US09/747,777
Other versions
US6624150B2 (en
Inventor
Benjamin Yerxa
Janet Rideout
William Pendergast
Sammy Shaver
Zhen Zhang
Ward Peterson
Matthew Cowlen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inspire Pharmaceuticals
Original Assignee
Inspire Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US12175499P priority Critical
Priority to US17171099P priority
Priority to US09/512,867 priority patent/US6331529B1/en
Application filed by Inspire Pharmaceuticals filed Critical Inspire Pharmaceuticals
Priority to US09/747,777 priority patent/US6624150B2/en
Assigned to INSPIRE PHARMACEUTICALS, INC. reassignment INSPIRE PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: COWLEN, MATTHEW, PENDERGAST, WILLIAM, PETERSON, WARD M., RIDEOUT, JANET, SHAVER, SAMMY, YERXA, BENJAMIN R., ZHANG, ZHEN
Publication of US20020052336A1 publication Critical patent/US20020052336A1/en
Application granted granted Critical
Publication of US6624150B2 publication Critical patent/US6624150B2/en
Application status is Expired - Fee Related legal-status Critical
Adjusted expiration legal-status Critical

Links